Company Name |
Country |
Omeros Ireland Limited |
Ireland |
Omnicin Therapeutics B.V. |
Netherlands |
Omnidos P.S.A. |
Poland |
ONCO-EUROPE Kft. |
Hungary |
Oncoheroes Biosciences S.L. |
Spain |
Oncoinvent AS |
Norway |
OncoNano Medicine Limited |
Ireland |
Onconova Europe GmbH |
Germany |
Oncopeptides AB |
Sweden |
Oncoradiomics S.A. |
Belgium |
Oncoral Pharma ApS |
Denmark |
Oncorena AB |
Sweden |
Oncoscience GmbH |
Germany |
Oncostellae S.L. |
Spain |
Oncovita |
France |
OncoZenge AB |
Sweden |
One-carbon Therapeutics |
Sweden |
OneChain Immunotherapeutics, S.L. |
Spain |
Oniria Therapeutics S.L. |
Spain |
ONK Therapeutics Limited |
Ireland |
Onkogen Kft. |
Hungary |
onkovis GmbH |
Germany |
Onni Biotechnologies Oy |
Finland |
OP Pharma S.R.L. |
Italy |
Op2Lysis |
France |
OPERON, S.A. |
Spain |
OPK Biotech Netherlands BV |
Netherlands |
Optimal Regulatory Solutions, S.L.U. |
Spain |
Opus Materia Ltd |
Greece |
ORBIT PHARMA LIMITED |
Ireland |
Orchard Therapeutics Netherlands B.V. |
Netherlands |
Oresund Pharma ApS |
Denmark |
Orexa B.V. |
Netherlands |
ORKEO |
France |
Orphalan |
France |
ORPHELIA Pharma |
France |
Orphelion AB |
Sweden |
Orphix Consulting GmbH |
Germany |
ORYX GmbH & Co. KG |
Germany |
Oryzon Genomics, S.A. |
Spain |
|